ReviewHuman vaccines & immunotherapeutics2023

Clinical trials show similar safety outcomes including febrile convulsion rates for GSK's and Merck's measles-mumps-rubella (MMR) vaccines.

Md Ahsan Habib et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.